Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,722.81
(
0.35%
)
US TECH 100
24,139.20
(
0.52%
)
Dow Jones
47,086.72
(
0.30%
)
Brent Oil
99.60
(
1.32%
)
Bitcoin
74,064.99
(
-1.04%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 118089

Thursday, 11/01/2012 1:16:49 PM

Thursday, November 01, 2012 1:16:49 PM

Post# of 257251
BAX inks FVIII-supply deal with Hemobrás of Brazil:

http://finance.yahoo.com/news/baxter-announces-long-term-partnership-130000285.html

Through this innovative partnership, Baxter will be the exclusive provider of Brazil’s recombinant FVIII treatment over the next 10 years while the companies work together on the technology transfer to support development of local manufacturing capacity by Hemobrás.

Note that patent protection is not part of the discussion, so this is effectively a deal for BAX to sell a branded generic in Brazil.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now